BACKGROUND: Implantable cardioverter defibrillator arrhythmia discrimination algorithms often are unable to discriminate ventricular from supraventricular arrhythmias. We sought to evaluate whether the response to antitachycardia pacing (ATP) in patients with an implantable cardioverter defibrillator could further discriminate ventricular from supraventricular arrhythmias in patients receiving ATP.
I
mplantable cardioverter defibrillators (ICDs) improve survival in patients known to be at risk of sudden cardiac death by detecting and terminating life-threatening ventricular arrhythmias. 1, 2 Inappropriate ICD therapy occurs in 16% to 31% of patients 3 because of incorrect arrhythmia classification. Inappropriate shocks are associated with psychological distress, anxiety, reduced quality of life, and increased mortality. 4, 5 Algorithms to differentiate ventricular from supraventricular arrhythmias have been developed. Although these differ based on the manufacturer and the type of ICD, the principles of these algorithms are universal. They include assessing the abruptness of the change in heart rate at the onset of tachycardia detection, the variability of the tachycardia cycle length (TCL), the difference in the ventricular electrogram morphology between tachycardia and baseline and assessing the ratio and relationship of the ventricular and atrial electrograms. Although the sensitivity and specificity of these discriminators vary depending on the algorithm, these discriminators generally sacrifice specificity in favor of sensitivity to avoid undertreatment of ventricular arrhythmias (sensitivity of 99%-100% and specificity of 78%-97%). [5] [6] [7] Antitachycardia pacing (ATP), which attempts to terminate the tachycardia by rapidly pacing the ventricle (overdrive pacing), is often effective in terminating ventricular tachycardia (VT) without the discomfort associated with an ICD shock and thus is recommended as the initial ICD treatment. 8, 9 When ATP fails to terminate the tachycardia, it may provide valuable information to distinguish ventricular from supraventricular arrhythmias. The postpacing interval (PPI), defined as the interval from the last paced beat to the first return electrogram, would be expected to be different between ventricular and supraventricular arrhythmias. As the difference between the PPI and the TCL correlates with the proximity of a pacing source to a reentry circuit, PPI−TCL would be expected to be shorter in arrhythmias where the ventricles are part of the circuit (VT and atrioventricular reentry tachycardia) than those where they are not (atrial flutter and atrioventricular nodal reentry tachycardia). [10] [11] [12] Furthermore, if ventricular overdrive pacing results in concealed retrograde penetration of the AV node, the PPI−TCL would be expected to be longer in atrial fibrillation and atrial tachycardia.
Previous analysis of 20 patients implanted with an ICD showed that measurement of the PPI−TCL found that this algorithm could discriminate between supra-
WHAT IS KNOWN?
• A long postpacing interval minus tachycardia cycle length after antitachycardia pacing delivered by an implantable cardioverter defibrillator is more likely to be a supraventricular than ventricular arrhythmia.
WHAT THE STUDY ADDS?
• The postpacing interval minus tachycardia cycle length provides clinically important arrhythmia discrimination incremental to commonly used implantable cardioverter defibrillator discriminators. • A cutoff value for postpacing interval minus tachycardia cycle length ≤360 ms can prevent 28.3% of inappropriate therapy without avoiding appropriate shocks.
ventricular tachyarrhythmia (SVT) and VT with an area under the curve (AUC) of 0.86. 13 The authors showed that using a cutoff value of <260 ms could discriminate VT from atrial fibrillation/atrial tachycardia with a sensitivity of 72.2% and a specificity of 78.1%.
Our primary aim was to assess the ability of the PPI-TCL interval to discriminate VT from supraventricular arrhythmias after failed ATP in ICDs. Furthermore, we sought to identify a cutoff value with a high VT sensitivity to allow for its integration in ICDs as a discrimination algorithm.
METHODS
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure as the primary study data continues to be subject to further analyses.
Study Population
All patients treated with ATP after enrollment in RAFT (CardiacResynchronization Therapy for Mild-to-Moderate Heart Failure Trial) were included. RAFT randomized 1798 patients with mild-to-moderate heart failure, ejection fraction of ≤30%, and a QRS duration of ≥120 ms to receive an ICD with or without cardiac resynchronization therapy between January 2003 and February 2009. 14 The mean follow-up time was 40±20 months. The majority (99.9%) of devices implanted were manufactured by Medtronic, Inc (Minneapolis, MN). Approval was given by each site's institutional review committee, and subjects gave informed consent to participate.
RAFT ICD Programming
Standardized programming and lead placement was protocol mandated as part of RAFT. The programming differed between single-and dual-chamber/cardiac resynchronization therapy devices. All devices were programmed into 3 zones. The programmed detection cycle lengths for VT, fast VT, and ventricular fibrillation zones were 150 to 200 beats per minute, 200 to 250 beats per minute, and >250 beats per minute. The programmed number of intervals to detect was of 18 out of 24 for initial detection and 12 out of 16 for redetection. The primary singlechamber discriminators were a QRS morphology discriminator (Wavelet) and a cycle length variability discriminator. PR logic, which discriminates based on the relationship between the atrial and ventricular electrograms, was the main discriminator in dualchamber and biventricular devices. The SVT limit was 300 ms, and SVT time out was turned off. For arrhythmias detected in the VT zone, therapy included 2 trains of burst ATP (8 beats at 88% of the TCL) followed by 1 train of ramp ATP (6 beats at 88% of TCL with 10 ms decrement). If these did not terminate the tachycardia, then a shock was delivered. Arrhythmias in the fast VT zone were treated with one train of ramp ATP (8 beats at 84% of TCL with 10 ms decrement). Tachycardias detected in the ventricular fibrillation zone were immediately shocked. Programming changes were allowed after implantation if clinically indicated. The right ventricular lead tip was mandated to be at the right ventricular apex and the sensing to be tip to ring.
Data Collection
The electrograms of all arrhythmia episodes treated with ATP were independently reviewed by both an experienced ICD technician and a cardiac electrophysiologist (Figure 1 ). These reviewers were blinded to clinical data with the exception of number of ICD leads (dual, single, or biventricular) as this was evident from the electrograms. Arrhythmia episodes were classified as monomorphic VT, polymorphic VT, ventricular fibrillation, sinus tachycardia, atrial fibrillation, atrial flutter, atrial tachycardia, or unknown SVT. In the event of uncertainty or disagreement regarding arrhythmia mechanism by the initial reviewers, another cardiac electrophysiologist who was blinded to the prior adjudications reviewed the episode. The level of certainty was classified as definite, probable, or unknown. Only episodes for which the adjudicators classified the rhythm adjudication as definite were included in the data analysis where those with a probable or unknown adjudication classification were excluded. Episodes without electrograms were not included. ATP was considered unsuccessful if the tachycardia persisted for at least 10 beats after the last paced beat within the ATP train. All ATP attempts, in each episode, were reviewed, and the PPI was recorded when ATP was unsuccessful. The PPI was defined as the interval between the stimulus of the final paced beat of ATP to the initial sensed electrogram of the first 
Data Analysis
Thirty percent of the patients who were found to have arrhythmias that met the inclusion/exclusion criteria were randomly chosen to serve as the derivation cohort. The measured PPI-TCL receiver operator curve (ROC) from the derivation cohort was used to identify a suitable cutoff to be tested in the remaining 70% of patients (validation cohort). A sensitivity of >97.5% was deemed acceptable for discrimination based on consensus by the authors based on the included TCLs.
Overdrive Suppression Pacing Maneuver Group
When using overdrive pacing to assess arrhythmias in the electrophysiology laboratory, certain characteristics are required before the assessment of PPI−TCL. 15 In this overdrive suppression pacing maneuver (OSPM) group, we included only arrhythmia episodes that met overdrive suppression maneuver criteria that could be reliably obtained from the ICD. The inclusion criteria for this group were fixed cycle length (burst) ATP, episodes where the mean TCL in the 10 cycle lengths before and after ATP did not change >30 ms, and the initial sensed event was not a paced beat, a PVC (defined as a different morphology or where the PPI<TCL), or oversensing. We did not attempt to assess whether the ATP captured the ventricle or resulted in tachycardia entrainment as the accuracy determining whether the circuit was entrained may have been poor resulting in a reduced ability to automate this into ICD programming.
Tachycardia Cycle Length
We also divided the validation cohort by TCLs (≤300, 301-399, and ≥400 ms) to determine the sensitivity and specificity of the PPI−TCL in these groups.
Statistical Analysis
Continuous variables are expressed as the mean±SD. Discrete values are expressed as their value (percentage). Student t test (or Wilcoxon rank-sum test) was used to compare continuous variables, and χ 2 test (or Fisher exact test) was used for categorical variables between the 2 groups. A generalized estimating equation with an exchangeable correlation structure function (logit link function) was used to account for repeated measures and account for the different number of events acquired from each patient. All statistical analysis was performed using SPSS version 21 (Armonk, NY). ROCs were created by graphing the sensitivity over (1−specificity) of the PPI−TCL. The AUC values for the PPI−TCL ROC were calculated through SPSS using the test variable (PPI−TCL) and state variable (VT).
RESULTS
In this study, 924 patients experienced 8150 tachycardia episodes, resulting in 10 916 ATP attempts that were reviewed. After discarding episodes where ATP terminated the arrhythmia (5207), the arrhythmia mechanism was not certain (897), 1194 ATP attempts in 647 episodes in 167 patients served as the derivation cohort, and 2482 ATP attempts in 1399 episodes in 374 patients as the validation cohort (Table 1 ; Data Supplement; Figure 2 ). The demographic and clinical characteristics were compared between the cardiac resynchronization therapy and non-cardiac resynchronization therapy groups, and there were no significant differences between the 2 groups for all variables (p>0.05). Overall, 199, 259, and 466 patients had a single, dual, and cardiac resynchronization therapy device.
Arrhythmia Mechanism
The details of the included arrhythmias are described in Table 2 . In derivation and validation cohorts, the majority of the included arrhythmias were ventricular in origin (78% and 68%, respectively). The most common supraventricular arrhythmias included in the derivation and validation cohorts were sinus tachycardia (47% and 36%, respectively) and atrial fibrillation (23% and 19%, respectively).
Derivation Cohort
The mean PPI−TCL for ventricular arrhythmias was 111.1±99.3 ms, and 235.1±120.2 ms for supraventricular arrhythmias (p<0.001). The AUC of the ROC that included all ATP attempts for all episodes in the derivation curve was AUC=0.804 (95% confidence interval [CI], 0.773-0.835). The ROC revealed that a PPI−TCL value of ≤360 ms would give a VT sensitivity of >97.5%, a value deemed acceptable for discrimination based on consensus by the authors.
Validation Cohort
The mean PPI−TCL for ventricular and nonventricular arrhythmias was 138.1±104.2 and 277.4±126.9 ms (p<0.001), respectively. The AUC of the ROC that included all ATP attempts for all episodes in the validation cohort was AUC=0.803 (95% CI, 0.784-0.822). The sensitivity and specificity for VT in the validation cohort for a cutoff value of ≤360 ms was 97.4% and 28.3%, respectively, for all ATP attempts for all episodes (Figure 3 ).
OSPM Group
Of the initial validation cohort, 1679 failed ATP attempts in 840 episodes in 173 patients were excluded from the OSPM group. The reasons for exclusion were nonfixed ATP cycle length (858 attempts), change in tachycardia cycle length or morphology (306 attempts), PVC or paced beat initially after ATP (369 attempts), or a com-bination of these exclusions (146). The sensitivity and specificity for VT in the OSPM validation cohort for a cutoff value of ≤360 ms was 98.6% and 38.4%, respectively, for all ATP attempts for all OSPM group episodes (AUC=0.801; 95% CI, 0.781-0.847). Fifty-nine percent (100/170) of the supraventricular arrhythmias in this subgroup received an ICD shock. Using a PPI−TCL cutoff ≤360 ms, where a shock would have been withheld if all of the PPI−TCL were >360 ms, 32 out of 100 (32%) shocks would have been avoided. Furthermore, if the same criteria were used for the 129 out of 389 (32.9%) VT episodes that received a shock, 0 out of 129 (0%) shocks would have been inappropriately withheld.
Effect of TCL on Discrimination
The number of ATP attempts, episodes, and patients stratified by mean TCL (≤300, 301-399, and ≥400 ms) is shown in Table 3 . In the validation cohort, the AUC for each TCL subgroup was 0.719 (95% CI, 0.631-0.807), 0.779 (95% CI, 0.755-0.803), and 0.757 (95% CI, 0.692-0.821) for ≤300, 301 to 400, and >400 ms, respectively. Furthermore, a PPI−TCL cutoff of ≤360 ms had a sensitivity and specificity of 98.6% and 4.8%, 97.1% and 30.5%, and 96.1% and 18.2% for the TCL of ≤300, 301 to 399, and ≥400 ms, respectively.
Effect of Biventricular ATP on PPI−TCL
In the validation cohort, 78 patients received biventricular ATP. In this group, ATP was delivered and unsuccessful 620 times (492 times for a ventricular arrhythmia and 128 times for a supraventricular arrhythmia). In this group, the ROC had an AUC of 0.750 (95% CI, 0.700-0.799). Furthermore, a PPI−TCL cutoff of ≤360 ms had a sensitivity and specificity for VT of 97.5% and 17.1%.
Efficacy of PPI−TCL in the Single-Lead ICD Cohort
In the validation cohort, 137 patients with single lead ICD devices had 501 unsuccessful ATP attempts (281 times for a ventricular arrhythmia and 220 times for a supraventricular arrhythmia). In this group, the ROC had an AUC of 0.828 (95% CI, 0.791-0.865). Furthermore, a PPI−TCL cutoff of ≤360 ms had a sensitivity and specificity for VT of 96.1% and 44.1%.
DISCUSSION
The primary finding of our study was that the PPI−TCL after unsuccessful ATP can be a useful discriminator in the differentiation of ventricular from supraventricular arrhythmias. The overall sensitivity and specificity for VT for a cutoff value of ≤360 ms was 97.4% and 28.3%, respectively, for all ATP attempts for all episodes in the validation cohort. The specificity and sensitivity was further improved by including only episodes treated with burst ATP, episodes with no change in TCL or electrogram morphology before, and episodes where the first return beat is not paced.
Discrimination Algorithms
ICD discrimination algorithms are designed to discriminate ventricular from supraventricular arrhythmias that have a sensitivity and specificity of 99% to 100% and 78% to 97%, [5] [6] [7] respectively. In our analysis, 22% and 32% of the arrhythmias treated with ATP in the derivation and validation cohorts had been incorrectly classified by the discrimination algorithms as VT. We have found that the PPI−TCL discriminator would allow for further discrimination and shock reduction without withholding appropriate ICD shocks.
Some discrimination algorithms require an atrial lead. Our proposed PPI−TCL discrimination algorithm does not require an atrial lead for its use. It can be used in single-chamber devices thus improving the discriminating ability of the ICD without the incremental risk of complications and cost of a dual-chamber device over a single-chamber device. 16, 17 We found that the AUC, sensitivity, and specificity were similar between the single-chamber cohort and the overall group that included the single, dual, and biventricular devices (Table 3) .
PPI−TCL at Different Rates
The MADIT-RIT trial (The Reduction in Inappropriate Therapy and Morality Through ICD Programming) showed that increasing the rate above which ICDs deliver therapy reduces both mortality and inappropriate shocks. 5 The use of the PPI−TCL had similar AUC values at different TCLs. The cutoff of ≤360 ms would further strengthen the ability to discriminate ventricular from supraventricular arrhythmias in the subgroup of arrhythmias at rates >200 beats per minute. We found that VT sensitivity was lower for a cutoff of ≤360 in the slower arrhythmia zones between 150 and 200 beats per minute. It is likely that, based on the results of MADIT-RIT, a reduced VT sensitivity is acceptable in this zone. However, if, based on patient-specific clinical characteristics, clinicians wished to increase the VT sensitivity, the cutoff value could be increased.
Previous Studies Assessing the Use of PPI−TCL in the Discrimination of VT From Non-VT Arrhythmias
Michael et al 13 have previously assessed the ability of the PPI−TCL to differentiate VT from nonventricular arrhythmias. They showed an AUC for PPI−TCL of 0.86 in 51 ATP attempts (18 atrial fibrillation/atrial tachycardia and 33 VT) whose inclusion/exclusion characteristics were similar to our overdrive suppression maneuver group. Our analysis builds on their initial findings in a larger cohort of 803 failed ATP attempts and had an AUC of 0.801. Michael et al found that using a PPI−TCL cutoff of <260 ms could discriminate VT from atrial fibrilla- tion/atrial tachycardia with a sensitivity of 72.2% and a specificity of 78.1%. Our analysis found that, although using a longer PPI−TCL cutoff value of ≤360 ms results in a reduction in VT specificity to 38.4%, it improves VT sensitivity to 98.6%, a level that is consistent with other clinically accepted discriminators.
Limitations
Although the most common arrhythmia with a short PPI−TCL when pacing in the ventricle is VT, other arrhythmias such as atrioventricular reentry tachycardia using a right-sided or septal accessory pathways or atrioventricular nodal reentry tachycardia will also be short (≤360 ms). 10, 18 In our cohort, which is a typical ICD population, the majority of patients were found to have arrhythmias consistent with mechanisms other than atrioventricular reentry tachycardia or atrioventricular nodal reentry tachycardia.
The frequency of each arrhythmia, the presence or absence of VA conduction, mechanism of VT (reentrant versus nonreentrant), and VT circuit location (near versus far from the pacing site) may affect the sensitivity and specificity of the PPI−TCL discrimination algorithm. Furthermore, there are many instances where right ventricular overdrive pacing does not equate to tachycardia entrainment. 19 However, we expect that the proportion of patients with each specific arrhythmia and the patient and arrhythmia electrophysiological characteristics (presence/absence of VA conduction and reentry versus automatic VT) to be typical of most populations of patients with an ICD and, as such, we expect our results to be generalizable those patients.
The use of antiarrhythmic drugs or other medications that may affect the PPI−TCL was not standardized in the enrolled patients. These drugs may have altered the PPI−TCL in certain patients which, in turn, would affect the generalizability of our cutoff value. We expect that this effect would be minor because only 15.8% of patients were taking antiarrhythmic drugs at the beginning of the study.
The ICDs used in RAFT used arrhythmia discrimination algorithms available in Medtronic devices at the time of enrollment for single-chamber, dual-chamber, and biventricular devices. As such, there may be an effect of different manufacturers' or current Medtronic discrimination algorithms for initial detection or redetection after ATP was delivered on the sensitivity and specificity than that found in our analysis. The algorithms in our analysis, although specific to Medtronic ICDs, follow similar principles to those of other manufacturers. As such, we expect that the non-Medtronic algorithms would result in a similar cohort of ATP attempts for the nonventricular arrhythmias seen in our cohort and would yield a similar sensitivity and specificity for the PPI−TCL cutoff. Similarly, ATP percent cycle lengths (ATP cycle lengths/TCLs) different than those used in our study may affect the sensitivity and specificity of this algorithm.
Conclusions
The addition of PPI−TCL and a cutoff value ≤360 ms resulted in a VT sensitivity and specificity of 97.4% and 28.3% when used in combination with programmed discrimination algorithms. Incorporation of a PPI−TCL ATP indicates antitachycardia pacing; CI, confidence interval; CL, cycle length; HR, heart rate; ICD, implantable cardioverter defibrillator; PPI, postpacing interval; SVT, supraventricular tachyarrhythmia; TCL, tachycardia cycle length; and VT, ventricular tachycardia.
